A Study to Evaluate the Efficacy of a Counselling and Advisory Care for Health (COACH) Program in Dyslipidemic Patients.

Last updated: February 17, 2021
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Overall Status: Completed

Phase

4

Condition

Dyslipidemia

Treatment

N/A

Clinical Study ID

NCT00708370
A2581162
  • Ages > 18
  • All Genders

Study Summary

This study is a local PCO sponsored, interventional, non-drug study to evaluate the efficacy of a health tele-counselling program in reducing cardiovascular risk in dyslipidemic patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Subjects who are newly diagnosed with dyslipidemias.
  2. Subjects must be lipid drug naive and eligible for statin therapy.

Exclusion

Exclusion Criteria:

  1. Subjects who cannot be contacted by telephone or handphone.
  2. Subjects with uncontrolled primary hypothyroidism.

Study Design

Total Participants: 297
Study Start date:
August 01, 2008
Estimated Completion Date:
June 30, 2010

Study Description

Educational / Counseling

Connect with a study center

  • Pfizer Investigational Site

    Jitra, Kubang Pasu, Kedah 06200
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kulim, Kedah 09400
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Sik, Kedah 08200
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kubang Kerian, Kelantan 16150
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Cheras, Kuala Lumpur 56000
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Nilai, Negeri Sembilan 71800
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Tampin, Negeri Sembilan 73000
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Bagan Serai, Perak 34300
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Lenggong, Perak 33400
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Slim River, Perak 35860
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kapar, Selangor 42200
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Petaling Jaya, Selangor 46000
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Puchong, Selangor 47100
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Sungai Buloh, Selangor 47000
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kemaman, Terengganu 24100
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kerteh, Kemaman, Terengganu 24300
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Kuala Lumpur, 50480
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Melaka, 75460
    Malaysia

    Site Not Available

  • Pfizer Investigational Site

    Shah Alam, 40460
    Malaysia

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.